emerg
highli
pathogen
human
coronavirus
hcov
last
two
decad
illumin
potenti
caus
high
morbid
mortal
human
popul
disrupt
global
economi
global
pandem
concern
stem
high
mortal
rate
capac
humantohuman
spread
respiratori
transmiss
complet
lack
approv
therapeut
countermeasur
limit
diseas
may
requir
develop
virusdirect
hostdirect
therapeut
strategi
due
acut
etiolog
hcov
infect
therefor
understand
hcovhost
interact
caus
pathogen
outcom
reli
upon
mammalian
model
close
recapitul
pathogenesi
hcov
human
pragmat
larg
drive
forc
underpin
mice
highli
effect
mammalian
model
elucid
hcovhost
interact
govern
pathogenesi
notabl
tractabl
mous
genet
combin
hcov
revers
genet
system
afford
concomit
manipul
viru
host
genet
evalu
virushost
interact
network
diseas
addit
assess
etiolog
known
hcov
mous
model
clinic
predict
valu
tool
apprais
potenti
diseas
phenotyp
associ
preemerg
cov
knowledg
cov
pathogen
potenti
cross
speci
barrier
human
popul
provid
highli
desir
preclin
platform
address
global
pathogen
prepared
overarch
direct
world
health
organ
although
recogn
result
obtain
robust
mous
model
requir
evalu
nonhuman
primat
focu
review
current
state
hcov
mous
model
use
tractabl
complex
genet
organ
untangl
complex
hcovhost
interact
pathogenesi
model
preclin
evalu
novel
therapeut
intervent
etiolog
coronavirus
cov
compris
extens
host
rang
includ
reptil
bird
pig
dog
cat
cattl
rodent
bat
camel
human
extens
nonhuman
host
rang
may
serv
reservoir
preemerg
coronavirus
pois
zoonot
transmiss
human
anim
popul
forni
et
al
zhou
et
al
six
known
human
coronavirus
sarscov
merscov
four
identifi
last
year
consid
bat
may
pinnacl
reservoir
origin
hcov
sarscov
merscov
evid
sarscov
merscov
indic
intermedi
zoonot
host
civet
cat
camel
respect
may
import
evolut
pathogen
cov
emerg
human
popul
forni
et
al
emerg
novel
pathogen
cov
human
popul
result
highli
lethal
respiratori
hcov
global
pandem
potenti
humantohuman
spread
underscor
global
spread
sarscov
mortal
ongo
reintroduct
merscov
mortal
human
arabian
peninsula
humantohuman
transmiss
merscov
appar
south
korean
outbreak
establish
singl
individu
return
visit
arabian
peninsula
result
individu
infect
mortal
rate
lee
high
mortal
rate
south
korea
also
establish
societywid
panic
led
sever
econom
toll
anticip
cut
gdp
rate
lee
hcov
emerg
human
new
tool
robust
mous
model
need
deciph
pathogen
mechan
ultim
understand
hcovhost
molecular
interact
network
regul
pathogenesi
guid
engin
therapeut
countermeasur
ideal
strategi
develop
model
recapitul
human
respiratori
cov
clearli
includ
develop
genet
tractabl
mammalian
model
effect
recapitul
human
pathogen
phenotyp
effici
revers
genet
system
seamless
manipul
hcov
genom
genet
control
host
hcov
genom
facilit
abil
draw
causeandeffect
relationship
virushost
genet
pathogen
outcom
revers
system
genet
tool
develop
manipul
larg
hcov
genom
kb
encod
nonstructur
protein
structur
protein
includ
spike
envelop
e
membran
nucleocapsid
n
number
accessori
protein
vari
sequenc
function
fig
review
cockrel
et
al
number
vitro
experi
biochem
tissu
cultur
base
demonstr
hcov
protein
interact
host
cell
protein
ensur
fidel
viru
replic
facilit
evas
host
cell
immun
respons
promin
hcovhost
cell
interact
major
determin
viral
tropism
spike
protein
host
cellspecif
receptor
spike
protein
form
trimer
surfac
viru
monom
harbor
receptor
bind
domain
rbd
interact
cognat
receptor
host
cell
sarscov
merscov
fig
spike
protein
especi
rbd
major
target
develop
antibodi
vaccin
therapeut
highli
conserv
structur
nonstructur
protein
chiefli
enzymat
protein
may
serv
target
broadli
effect
antihcov
therapeut
target
accessori
protein
conserv
hcov
numer
studi
reveal
gene
set
encod
critic
determin
speciesspecif
pathogenesi
modul
host
immun
respons
fig
vitro
studi
shown
number
accessori
protein
import
evas
host
innat
immun
respons
interact
host
protein
review
de
wit
et
al
totura
baric
although
vitro
studi
imper
understand
molecular
biochem
mechan
vivo
studi
deciph
complex
hcovhost
interact
relat
pathogen
phenotyp
follow
respiratori
infect
discern
fine
balanc
pathogenesi
protect
govern
relationship
host
innat
adapt
immun
respons
requir
develop
mammalian
model
effect
recapitul
pathogenesi
respiratori
hcov
challeng
associ
model
pathogenesi
emerg
preemerg
hcov
born
model
develop
sarscov
merscov
last
year
tabl
fig
mice
ferret
nonhuman
primat
nhp
tradit
use
studi
involv
respiratori
pathogen
among
speci
initi
investig
sarscov
merscov
replic
pathogenesi
lung
take
account
number
practic
consider
compar
model
sarscov
merscov
mous
model
appear
pragmat
tabl
although
emphas
practic
hcov
mous
model
purpos
review
absolut
critic
need
robust
primat
model
downstream
drug
vaccin
test
import
note
research
eg
efficaci
therapeut
countermeasur
establish
robust
mous
model
effect
translat
larg
anim
model
nhp
close
reflect
human
physiolog
gener
mous
model
sarscov
merscov
afford
readili
avail
requir
fig
emerg
preemerg
coronaviru
genom
organ
gene
green
encod
nonstructur
protein
highli
conserv
throughout
coronavirus
structur
gene
red
encod
structur
protein
spike
envelop
e
membran
nucleocapsid
n
common
coronavirus
accessori
gene
dark
shade
uniqu
differ
coronavirus
regard
number
genom
organ
sequenc
function
nomin
train
handl
amen
manipul
condit
amen
analysi
commerci
avail
molecular
reagent
amen
larg
number
purpos
experiment
reproduc
genet
tractabl
tabl
despit
common
establish
mous
model
merscov
present
challeng
encount
sarscov
tabl
even
year
first
case
merscov
one
biggest
challeng
remain
limit
understand
patholog
merscov
human
two
studi
describ
patholog
merscov
two
fatal
human
case
alsaad
et
al
ng
et
al
two
fatal
human
merscov
case
similar
observ
case
sarscov
wherein
patient
exhibit
sever
acut
respiratori
distress
diffus
alveolar
damag
format
hyalin
membran
alveolar
fibrin
deposit
edema
hemorrhag
cellular
debri
alveolar
interstiti
inflamm
throughout
lung
extens
pulmonari
tissu
necrosi
alsaad
et
al
ng
et
al
fatal
case
sarscov
merscov
commonli
associ
gradual
loss
respiratori
function
avail
intervent
restrict
mechan
respiratori
support
oxygen
supplement
review
therefor
effect
mous
model
sarscov
merscov
minim
abl
recapitul
fatal
respiratori
diseas
patholog
similar
observ
human
describ
number
mous
model
exhibit
fatal
respiratori
diseas
develop
sarscov
merscov
howev
singl
impedi
realiz
earli
model
develop
merscov
confront
sarscov
mous
orthologu
human
receptor
merscov
dipeptidyl
peptidas
support
interact
merscov
spike
glycoprotein
rbd
cockrel
et
al
therefor
unlik
sarscov
commerci
avail
mice
suscept
merscov
towler
et
al
order
establish
lethal
mous
model
spike
protein
genom
determin
modifi
adapt
evolut
mous
lung
day
et
al
frieman
et
al
robert
et
al
therebi
mous
subspeci
exhibit
unalt
mous
infect
mouseadapt
sarscov
wildtyp
merscov
column
green
merscov
infect
human
via
interact
spike
protein
rcsb
pdb
id
yuan
et
al
cognat
receptor
rcsb
pdb
id
feng
et
al
merscov
spike
protein
abl
interact
mous
orthologu
human
cockrel
et
al
coleman
et
al
therefor
mous
gene
genet
modifi
order
allow
infect
merscov
cockrel
et
al
li
et
al
pascal
et
al
preemerg
cov
column
grey
preemerg
cov
use
either
known
human
receptor
cov
ge
et
al
menacheri
et
al
wang
et
al
yang
et
al
yang
et
al
novel
unknown
receptor
infect
host
genet
highli
divers
panel
mous
strain
collabor
cross
potenti
provid
mous
model
studi
newli
emerg
cov
due
high
genet
variabl
present
resourc
viru
imag
yellow
repres
envelop
protein
lightdark
blue
repres
membran
protein
red
repres
nucleocapsid
protein
infect
replic
coleman
et
al
suscept
merscov
pathogenesi
achiev
use
uniqu
approach
genet
engin
mice
describ
detail
establish
mous
model
fatal
diseas
sarscov
merscov
afford
necessari
knowledg
institut
preclin
vivo
platform
use
evalu
preemerg
hcov
respiratori
pathogen
unknown
diseas
outcom
fig
strategi
wide
portabl
import
human
pathogen
replic
poorli
mous
need
sarscov
mous
model
recogn
shortli
sarscov
outbreak
spread
global
three
differ
strategi
employ
develop
sarscov
mous
model
differ
mous
speci
subspeci
challeng
wildtyp
human
sarscov
isol
order
find
model
allow
replic
reflect
sever
respiratori
diseas
symptom
observ
infect
human
patient
ii
mice
genet
engin
modifi
host
receptor
facilit
product
sarscov
replic
pathogenesi
iii
adapt
evolut
wildtyp
sarscov
chosen
mous
speci
done
enhanc
pathogenesi
associ
clinic
phenotyp
vivo
initi
studi
develop
mous
model
sarscov
evalu
suscept
variou
mous
subspeci
clinic
isol
sarscov
earli
first
studi
use
mous
model
organ
sarscov
report
week
old
femal
balbc
mice
intranas
infect
clinic
isol
sarscov
urbani
effici
viral
replic
observ
upper
lower
respiratori
tract
peak
titer
day
clearanc
day
wherea
viral
replic
detect
organ
howev
mice
continu
gain
weight
show
sign
clinic
diseas
passiv
transfer
immun
sera
mice
suffici
prevent
viral
replic
respiratori
tract
indic
wildtyp
sarscov
could
elicit
effect
humor
immun
respons
nonetheless
absenc
pathogenesi
clinic
sign
diseas
difficult
properli
evalu
efficaci
therapeut
countermeasur
second
studi
glass
et
al
use
mice
known
exhibit
immun
respons
contrast
balbc
mice
tabl
practic
consider
establish
effect
hcov
anim
model
yesrequir
viru
adapt
b
yesaft
genet
engin
mous
c
affordabilitymor
cost
effect
rel
ferret
nhp
model
availabilitydevelop
model
readili
acquir
studi
broader
scientif
commun
e
eas
handlingmic
requir
least
amount
special
train
compar
ferret
nhp
f
amen
conditionsmic
amen
condit
due
space
limit
special
handl
requir
personnel
limit
g
maybedepend
speci
techniqu
h
ndnot
determin
consid
glass
et
al
may
account
differ
pathogen
outcom
like
balbc
studi
week
old
mice
infect
clinic
sarscov
urbani
isol
infect
mice
exhibit
slower
weight
gain
mockinfect
mice
sarscov
found
upper
lower
respiratori
tract
also
brain
associ
clinic
diseas
human
develop
sarscov
model
mice
ad
benefit
expand
applic
model
genet
modifi
knockout
ko
mice
predominantli
gener
background
therebi
facilit
investig
host
genet
sarscov
pathogenesi
glass
et
al
util
rag
knockout
mice
glass
et
al
demonstr
nk
cell
nkt
cell
b
lymphocyt
requir
clearanc
sarscov
mous
glass
et
al
initi
studi
evalu
differ
murin
subspeci
model
sarscov
result
replic
respiratori
tract
indic
clinic
pathogenesi
often
observ
human
case
experienc
sever
respiratori
distress
knockout
mice
defici
innat
immun
respons
first
exhibit
clinic
alter
includ
weight
loss
progress
worsen
pulmonari
diseas
hogan
et
al
mice
background
infect
sarscov
clinic
isol
show
requir
resolut
sarscov
infect
clinic
sign
diseas
observ
ko
mice
wherea
effici
viral
replic
lower
respiratori
tract
caus
clinic
symptom
wildtyp
mice
contrast
mice
support
viral
replic
peak
titer
day
persist
throughout
day
hogan
et
al
featur
patholog
found
mice
differ
found
human
howev
patholog
featur
common
human
bronchiolar
injuri
focal
respiratori
epitheli
cell
necrosi
support
idea
mous
speci
could
good
model
sarscovassoci
clinic
find
observ
respiratori
tract
infect
human
patient
increas
fatal
consequ
acut
respiratori
distress
syndrom
ard
sarscov
infect
often
associ
advanc
age
year
old
human
booth
et
al
donnelli
et
al
tsui
et
al
exploit
improv
mous
model
sarscov
pathogenesi
replic
advanc
age
human
month
old
balbc
robert
et
al
robert
et
al
mice
intranas
infect
clinic
isol
sarscov
urbani
balbc
mice
show
compar
level
kinet
viral
replic
age
mice
clear
sarscov
day
robert
et
al
predomin
clinic
featur
regard
mous
studi
weight
loss
consequ
appetit
loss
dehydr
three
line
age
mice
show
transient
sign
clinic
diseas
includ
weight
loss
ruffl
fur
hunch
dehydr
resolv
day
moreov
three
strain
exhibit
histopatholog
find
perivascular
peribronchiolar
infiltr
necrot
debri
bronchiol
interstiti
pneumon
importantli
extens
alveolar
damag
age
balbc
mice
persist
day
postinfect
pi
find
close
resembl
patholog
observ
human
first
control
studi
demonstr
differ
host
genet
significantli
influenc
sarscov
pathogenesi
topic
revisit
regard
use
tractabl
popul
genet
distinct
mice
refer
collabor
cross
concurr
studi
rockx
et
al
demonstr
pathogenesi
relat
sarscov
clinic
isol
also
depend
upon
genet
sarscov
strain
evalu
vivo
rockx
et
al
use
revers
genet
rockx
et
al
modifi
spike
protein
sarscov
urbani
strain
encod
spike
middl
earli
phase
clinic
isol
civet
strain
spike
gene
hc
rockx
et
al
infecti
clone
harbor
clinic
isol
civet
spike
exhibit
sever
weight
loss
death
well
patholog
consist
acut
respiratori
distress
syndrom
age
young
mice
rockx
et
al
despit
earli
achiev
age
mice
sarscov
mous
model
develop
impract
maintain
larg
coloni
age
mice
immun
senesc
age
mice
may
complic
studi
involv
pathogenesi
effect
evalu
immun
respons
therapeut
countermeasur
addit
limit
fulllength
clinic
isol
sarscov
shown
lethal
age
mice
clinic
outcom
impact
nearli
human
case
lethal
achiev
use
clinic
sarscov
isol
variou
young
wildtyp
immuneincompet
mous
strain
mind
attent
turn
genet
modif
mice
acquir
lethal
model
sarscov
pathogenesi
order
continu
work
unalt
human
clinic
isol
sarscov
mous
strain
constitut
express
human
receptor
sarscov
human
angiotensin
convert
enzym
gener
logic
follow
human
clinic
isol
sarscov
evolv
use
receptor
effect
innat
mous
receptor
therefor
may
elicit
patholog
consist
lethal
respiratori
infect
differ
constitut
promotor
use
express
mice
cytokeratin
promotor
mccray
et
al
netland
et
al
chicken
betaactin
promotor
cytomegaloviru
ie
enhanc
tseng
et
al
mous
promotor
yang
et
al
express
level
human
correl
diseas
sever
transgen
mous
model
human
overexpress
mice
gener
cytokeratin
promot
promot
attempt
limit
express
respiratori
cell
cell
exhibit
innat
receptor
express
respect
mccray
et
al
netland
et
al
yang
et
al
even
though
transgen
mice
show
infect
airway
epithelium
exhibit
high
level
express
brain
transgen
mice
support
increas
viral
load
brain
tissu
mccray
et
al
netland
et
al
tseng
et
al
yang
et
al
increas
viral
load
brain
infect
anim
ultim
led
mortal
caus
extens
dissemin
enceph
brain
mccray
et
al
netland
et
al
tseng
et
al
yang
et
al
accordingli
despit
success
gener
lethal
overexpress
mous
model
sarscov
pathogenesi
neurologicalrel
mortal
confound
valu
model
could
effect
mimic
lethal
respiratori
diseas
often
observ
infect
human
adapt
experiment
evolut
stapl
virolog
year
kalter
provid
critic
insight
pathogen
mechan
bestow
robust
lethal
mous
model
interrog
efficaci
vaccin
therapeut
boll
et
al
cockrel
et
al
rasmussen
et
al
robert
et
al
adapt
experiment
evolut
perform
serial
vivo
passag
tissu
interest
adapt
viru
host
innat
adapt
immun
respons
similar
ongo
battl
viru
host
immun
respons
occur
natur
expedit
timescal
tissuespecif
manner
tissuespecif
adapt
evolut
place
viru
select
pressur
mutat
allow
effici
replic
adapt
sarscov
caus
sever
acut
respiratori
diseas
mous
lung
femal
balbc
mice
intranas
infect
clinic
urbani
isol
robert
et
al
process
repeat
round
sign
clinic
diseas
observ
predominantli
weight
loss
reach
clinic
endpoint
human
euthanasia
consid
human
lethal
robert
et
al
result
mouseadapt
sarscov
design
rapid
weight
loss
accompani
high
viral
titer
lung
viremia
dissemin
extrapulmonari
site
lymphopenia
neutrophilia
histopatholog
chang
lung
commonli
associ
pneumon
accordingli
mortal
consequ
extens
viral
replic
led
virusassoci
destruct
pneumocyt
epitheli
cell
six
code
mutat
suffici
render
sarscov
urbani
human
clinic
isol
lethal
week
old
week
old
age
balbc
mice
robert
et
al
sarscov
sinc
use
multitud
studi
proven
caus
lethal
diseas
balbc
mice
also
mous
strain
deng
et
al
frieman
et
al
gralinski
et
al
gralinski
et
al
totura
et
al
zhao
et
al
addit
passag
result
gener
mouseadapt
sarscov
strain
includ
passag
frieman
et
al
independ
research
group
acquir
lethal
sarscov
model
passag
human
urbani
isol
round
lung
balbc
mice
result
day
et
al
addit
acquir
lethal
sarscov
model
diseas
compar
variou
passag
mouseadapt
sarscov
provid
uniqu
advantag
abl
identifi
sarscov
protein
acquir
specif
mutat
elicit
sever
respiratori
phenotyp
identif
adapt
mutat
acquir
specif
sarscov
protein
provid
insight
virushost
interact
network
may
use
develop
virusdirect
therapeut
countermeasur
combin
mouseadapt
sarscov
strain
mous
model
support
interrog
host
genom
molecul
influenc
sarscov
pathogenesi
reveal
import
interact
node
amen
hostdirect
therapeut
intervent
mention
number
earli
sarscov
mous
model
studi
show
diseas
progress
outcom
mous
strain
depend
indic
host
genet
consider
influenc
sarscov
pathogenesi
surpris
sinc
human
gene
associ
studi
indic
differ
individu
genet
may
govern
suscept
clinic
outcom
respiratori
viral
pathogenesi
everitt
et
al
forton
et
al
kenney
et
al
mill
et
al
pasanen
et
al
patarc
et
al
zhou
et
al
includ
retrospect
studi
sarscovinfect
patient
chan
et
al
ching
et
al
wang
et
al
zhu
et
al
howev
human
genet
associ
indic
causeandeffect
requir
capac
model
impact
host
genet
respiratori
viral
pathogenesi
case
sarscov
pathogenesi
recent
develop
innov
resourc
genet
map
call
collabor
cross
cc
compris
panel
recombin
inbr
mous
strain
contain
tractabl
genet
divers
approach
genet
divers
human
popul
churchil
et
al
threadgil
et
al
use
octoparent
breed
scheme
includ
classic
laboratori
stain
aj
mous
model
human
diseas
nodshiltj
diabet
nzohlltj
obes
wildderiv
mous
strain
casteij
pwkphj
wsbeij
cc
captur
genet
variat
present
three
major
mous
subspeci
mu
musculu
musculu
mu
musculu
domesticu
mu
musculu
castaneu
robert
et
al
viru
infect
studi
cc
mous
line
includ
sarscov
led
map
high
low
host
respons
allel
relat
develop
clinic
sign
diseas
follow
viral
pathogenesi
bottomli
et
al
brinkmeyerlangford
et
al
ferri
et
al
gralinski
et
al
gralinski
et
al
green
et
al
rasmussen
et
al
rapid
genet
map
success
compar
analysi
cc
strain
show
extrem
phenotyp
high
versu
low
weight
loss
high
versu
low
lung
titer
extrem
phenotyp
select
cc
strain
may
reflect
clinic
outcom
observ
human
diseas
observ
test
mouseadapt
ebola
viru
differ
cc
strain
appli
cc
technolog
sarscov
pathogenesi
identifi
two
cc
strain
unc
oppos
suscept
profil
genet
map
reveal
adaptor
protein
tolllik
receptor
pathway
strong
candid
drive
sever
respiratori
diseas
phenotyp
base
observ
cc
mous
platform
use
identifi
novel
mous
model
recapitul
human
clinic
outcom
result
pathogen
virus
cc
mous
strain
extraordinarili
power
platform
establish
novel
mous
model
emerg
preemerg
isol
respiratori
coronavirus
har
power
cc
host
genet
map
support
identif
novel
hcovhost
molecular
interact
network
subsequ
valid
genet
engin
mice
innov
gene
edit
technolog
talen
synthet
zinc
finger
augment
effici
genet
engin
mice
make
genom
modif
ie
allelespecif
mutat
allel
swap
knockout
knockin
feasibl
multipl
mous
speci
largescal
doench
kim
kim
coincident
advanc
crispr
technolog
overlap
outbreak
merscov
fortuit
develop
lethal
merscov
mous
model
build
expertis
sarscov
outbreak
coronaviru
research
immedi
recogn
overwhelm
need
effect
merscov
mous
model
follow
emerg
merscov
howev
research
perplex
find
mous
line
convent
suscept
sarscov
infectionrepl
complet
resist
infect
clinic
merscov
isol
coleman
et
al
initi
studi
demonstr
nonhuman
primat
suscept
clinic
isol
merscov
de
wit
et
al
falzarano
et
al
johnson
et
al
johnson
et
al
munster
et
al
therefor
inabl
infect
mice
merscov
like
due
restrict
host
immun
respons
valid
immuneincompet
mous
line
also
lack
capac
infectionrepl
merscov
coleman
et
al
concurr
initi
merscov
studi
mice
raj
et
al
identifi
novel
receptor
merscov
human
dipeptidyl
peptidas
raj
et
al
unlik
sarscov
could
infect
mice
interact
rbd
spike
protein
receptor
mous
support
interact
merscov
spike
protein
cockrel
et
al
crystal
structur
merscov
interfac
reveal
number
specif
amino
acid
necessari
interact
rbd
spike
two
specif
domain
refer
blade
iv
v
structur
structur
lu
et
al
wang
et
al
ectop
express
studi
mous
receptor
reveal
alter
minimum
two
amino
acid
posit
confer
suscept
human
fibroblast
cell
line
merscov
infect
cockrel
et
al
peck
et
al
importantli
mice
nlink
glycosyl
site
may
steric
hinder
merscov
infect
present
orthologu
suscept
speci
includ
human
nhp
bat
camel
peck
et
al
appar
ferret
hamster
may
also
similar
glycosyl
may
explain
inabl
merscov
also
infectrepl
convent
small
anim
model
de
wit
et
al
peck
et
al
raj
et
al
van
doremalen
et
al
speciesspecif
challeng
util
receptor
limit
develop
mous
model
stymi
develop
small
anim
model
requir
evalu
therapeut
countermeasur
accordingli
initi
develop
mous
model
merscov
requir
employ
number
method
focus
engin
mice
expressoverexpress
human
receptor
agraw
et
al
li
et
al
zhao
et
al
zhao
et
al
fig
first
mous
model
develop
zhao
et
al
establish
transient
express
human
airway
balbc
mice
mice
sever
knockout
mice
use
adenovir
vector
transduc
overexpress
cassett
lung
mice
zhao
et
al
transient
express
render
mice
suscept
clinic
isol
merscov
infect
plaqu
form
unit
pfu
dose
support
viral
replic
lung
produc
transient
weight
loss
mild
pneumonia
particularli
older
immunodefici
mice
zhao
et
al
mortal
sign
advanc
clinic
respiratori
diseas
observ
zhao
et
al
platform
strategi
could
appli
novel
emerg
virus
model
provid
mean
rapidli
evalu
merscovdirect
therapeut
countermeasur
regard
interf
replic
lung
infect
mice
nevertheless
model
effect
mean
understand
therapeut
countermeasur
could
prevent
develop
sever
respiratori
diseas
result
mortal
infect
human
case
develop
clinic
relev
mous
model
number
group
turn
convent
knockin
approach
result
ubiquit
constitut
overexpress
throughout
mous
fig
agraw
et
al
report
develop
robust
merscov
mous
model
place
express
cag
promot
agraw
et
al
infect
clinic
isol
merscov
result
high
viral
load
lung
produc
sever
respiratori
diseas
fatal
day
postinfect
agraw
et
al
howev
diseas
confound
high
viral
load
extrapulmonari
tissu
includ
brain
heart
spleen
kidney
intestin
agraw
et
al
independ
studi
zhao
et
al
demonstr
multiorgan
damag
overexpress
mous
model
employ
promot
zhao
et
al
merscov
viral
load
nearli
two
log
higher
brain
infect
mice
lung
correspond
viral
enceph
observ
brain
day
mice
exhibit
sign
paralysi
zhao
et
al
li
et
al
went
step
gener
overexpress
model
goal
restrict
express
epitheli
cell
two
differ
model
gener
use
either
cytokeratin
surfact
c
protein
spc
promot
drive
express
mous
line
deriv
cassett
exhibit
mortal
sign
respiratori
diseas
contrast
infect
mice
pfu
merscov
clinic
isol
produc
weight
loss
lung
hemorrhag
mortal
day
pi
lung
patholog
consist
sever
respiratori
diseas
unfortun
promot
limit
merscov
infect
lung
instead
high
viral
load
brain
infect
mice
caus
neurolog
diseas
consist
observ
mortal
novel
genet
engin
approach
pascal
et
al
employ
regeneron
velocigen
technolog
precis
replac
entir
code
region
kb
gene
includ
kb
sequenc
encod
intron
exon
pascal
et
al
fig
despit
remov
nearli
entir
gene
untransl
region
maintain
therebi
retain
endogen
promot
rna
termin
region
confer
express
level
tissu
distribut
similar
obtain
infect
pfu
merscov
clinic
isol
result
viral
replic
lung
mild
clinic
diseas
patholog
indic
inflamm
weight
loss
mortal
day
pi
pascal
et
al
subsequ
studi
velocigen
mice
compris
detail
evalu
model
wherein
mice
infect
pfu
achiev
dramat
weight
loss
mortal
use
cutoff
day
pi
c
sequenc
use
velocigen
knockin
mous
model
pascal
et
al
mous
genom
sequenc
exon
stop
codon
exon
delet
replac
exon
exon
portion
untransl
sequenc
human
genom
sequenc
sequenc
use
knockin
model
li
et
al
mous
genom
sequenc
codon
exon
codon
exon
replac
human
equival
e
sequenc
use
mous
model
cockrel
et
al
technolog
use
make
substitut
exon
substitut
exon
mous
f
construct
use
overexpress
mous
model
construct
includ
cdna
human
flank
constitut
promot
polyadenyl
signal
regulatori
element
agraw
et
al
genom
region
human
cytokeratin
human
surfact
protein
c
coleman
et
al
lung
patholog
indic
mice
develop
moder
sign
respiratori
infect
littl
indic
sever
respiratori
diseas
studi
also
first
indic
cell
macrophag
play
signific
role
merscov
pathogenesi
coleman
et
al
importantli
merscov
infect
replic
primarili
lung
littl
involv
extrapulmonari
tissu
coleman
et
al
pascal
et
al
lack
brain
lesion
model
signific
advanc
transgen
model
reli
globalubiquit
express
nonetheless
model
readili
avail
scientif
commun
regeneron
model
obtain
come
number
commerci
restrict
regeneron
limit
util
consid
develop
therapeut
countermeasur
declar
author
manuscript
anoth
limit
often
overlook
express
model
innat
function
evolv
speciesspecif
manner
maintain
variou
physiolog
process
inher
host
alter
activ
andor
express
associ
mani
patholog
condit
includ
psychoneuroendocrin
disord
solid
tumor
cancer
hematolog
malign
infecti
diseas
autoimmuneinflammatori
diseas
klemann
et
al
enorm
biolog
breadth
predominantli
enzymat
activ
wherein
cleav
amino
termin
dipeptid
variou
biolog
substrat
lalanin
lprolin
penultim
posit
klemann
et
al
one
import
physiolog
process
also
known
modif
numer
cytokin
chemokin
involv
mainten
immunolog
homeostasi
klemann
et
al
ohnuma
et
al
cell
surfac
molecul
cell
influenc
numer
immunolog
process
includ
cell
activ
prolifer
cytokin
product
differenti
immunoglobulin
produc
plasma
cell
transendotheli
migrat
ohnuma
et
al
therefor
overexpress
fulllength
replac
fulllength
knockin
mous
model
may
significantli
alter
inher
biolog
immunolog
process
evolv
execut
speciesspecif
manner
mous
ultim
express
result
modifi
immun
respons
mice
could
artifici
influenc
pathogen
outcom
merscov
infect
immunolog
respons
central
evalu
efficaci
therapeut
countermeasur
goal
recent
gener
mous
model
genet
modifi
receptor
would
amen
interact
merscov
spike
rbd
subsequ
infect
therebi
avoid
need
introduc
receptor
achiev
merscov
suscept
minim
modif
would
central
limit
function
alter
could
interfer
broad
influenc
multipl
host
physiolog
process
cockrel
et
al
util
technolog
make
two
amino
acid
substitut
gene
mice
cockrel
et
al
fig
discuss
vitro
overexpress
modifi
previous
found
alter
suscept
cell
line
merscov
infect
cockrel
et
al
peck
et
al
mice
modifi
refer
mice
encod
amino
acid
substitut
chromosom
character
model
demonstr
innat
express
profil
physiolog
process
influenc
glucos
metabol
cell
activ
alter
two
amino
acid
modif
mice
infect
variou
isol
merscov
clinic
isol
camel
isol
molecular
clone
support
high
viral
replic
lung
fail
exhibit
clinic
sign
diseas
cockrel
et
al
adapt
evolut
round
serial
passag
mice
yield
mouseadapt
merscov
capabl
achiev
lethal
decreas
respiratori
function
lung
patholog
indic
sever
acut
respiratori
distress
syndrom
viral
dose
pfu
cockrel
et
al
merscov
infect
mice
exhibit
sever
respiratori
diseas
absent
detect
viru
brain
develop
sever
respiratori
diseas
mortal
could
prevent
use
merscov
spikedirect
vaccin
prophylact
administr
antibodi
therapeut
cockrel
et
al
although
model
highli
effect
studi
merscov
pathogenesi
evalu
therapeut
countermeasur
high
infecti
dose
pfu
requir
achiev
sever
respiratori
diseas
mortal
left
room
improv
addit
round
passag
result
mouseadapt
viru
capabl
achiev
similar
sever
respiratori
diseas
mortal
substanti
lower
dose
pfu
dougla
et
al
overal
limit
chang
receptor
two
amino
acid
research
abl
minim
disrupt
natur
express
level
distribut
biolog
function
merscov
mous
model
continu
central
role
studi
investig
merscov
pathogenesi
therapeut
countermeasur
menacheri
et
al
c
recent
mous
model
consist
genet
modifi
receptor
replac
exon
includ
intron
locu
equival
result
minim
knockin
mous
model
refer
li
et
al
fig
modif
model
much
smaller
regeneron
fulllength
knockin
model
larger
two
amino
acid
modif
model
place
somewher
two
type
model
regard
biolog
immunolog
function
clear
modifi
model
alter
express
biodistribut
function
profil
compar
wildtyp
receptor
nevertheless
mice
suscept
infect
clinic
isol
merscov
result
high
level
viral
replic
lung
sign
respiratori
diseas
mouseadapt
merscov
achiev
serial
passag
merscov
induc
sever
respiratori
diseas
accompani
high
mortal
infecti
dose
pfu
li
et
al
similar
model
model
exhibit
littl
involv
extrapulmonari
tissu
merscov
pathogenesi
li
et
al
mouseadapt
virus
acquir
li
et
al
reveal
uniqu
mutat
specif
viral
protein
may
critic
achiev
evad
host
immun
respons
comparison
virus
obtain
dougla
et
al
demonstr
chang
amino
acid
merscov
spike
protein
may
critic
achiev
lethal
infect
low
infecti
dose
dougla
et
al
li
et
al
importantli
mutat
present
earlier
passag
cockrel
et
al
model
requir
high
infecti
dose
achiev
sever
respiratori
diseas
lethal
cockrel
et
al
mouseadapt
virus
use
cockrel
et
al
dougla
et
al
li
et
al
help
provid
insight
adapt
evolut
identifi
specif
mutat
region
viru
import
enhanc
viru
fidel
host
andor
evad
host
immun
respons
adapt
merscov
notabl
occur
spike
region
import
determin
host
tropism
adapt
merscov
strain
mutat
region
may
provid
accur
represent
observ
viral
pathogenesi
human
current
achiev
lethal
diseas
mice
clinic
isol
merscov
requir
express
fulllength
demonstr
regeneron
knockin
mice
howev
alter
significantli
overexpress
replac
disrupt
immunolog
homeostasi
anim
make
difficult
analyz
diseas
etiolog
immun
respons
therapeut
countermeasur
merscov
mous
model
would
ideal
involv
infect
clinic
merscov
isol
unmodifi
mous
one
possibl
util
cc
mice
describ
sarscov
offer
wider
rang
genet
variat
genet
engin
mice
use
current
establish
mous
model
howev
unlik
sarscov
cc
mice
suscept
merscov
cross
variou
cc
line
mice
minim
alter
eg
mice
direct
genet
engin
cc
line
use
technolog
produc
mous
line
maintain
nativ
mous
express
distribut
function
profil
screen
differenti
suscept
clinic
isol
merscov
capac
genet
engin
receptor
alter
mous
suscept
hcov
infect
combin
adapt
hcov
evolut
genet
divers
cc
mous
strain
establish
platform
use
evalu
pathogenesi
preemerg
hcov
unknown
etiolog
mous
tool
found
studi
sarscov
merscov
pathogenesi
aid
understand
specif
preemerg
cov
pathogen
potenti
mammalian
model
sever
respiratori
diseas
hcov
sar
mer
consid
origin
bat
review
forni
et
al
menacheri
et
al
metagenom
analysi
variou
bat
speci
identifi
divers
repertoir
sarslik
slbcov
merslik
mlbcov
bat
coronavirus
ge
et
al
ge
et
al
et
al
lau
et
al
lau
et
al
lau
et
al
wu
et
al
yang
et
al
preemerg
potenti
includ
slcov
shown
util
receptor
ge
et
al
menacheri
et
al
yang
et
al
mlcov
demonstr
util
receptor
infect
yang
et
al
notabl
preemerg
cov
directli
isol
bat
fece
vero
cell
shown
replic
variou
cell
line
express
human
nhp
receptor
ge
et
al
yang
et
al
contrast
isol
demonstr
infect
cell
rather
lentivir
particl
pseudotyp
spike
protein
support
effici
bind
infect
cell
express
yang
et
al
structur
cov
spike
protein
context
pseudotyp
lentivir
particl
may
differ
cov
particl
may
account
difficulti
infect
replic
cell
express
spike
protein
mani
preemerg
bat
cov
bcov
amino
acid
differ
preclud
effici
interact
known
human
host
receptor
transmiss
intermedi
host
civet
camel
human
may
requir
addit
adapt
spike
protein
review
graham
baric
menacheri
et
al
therefor
evalu
pathogenesi
preemerg
bcov
mous
model
spike
protein
replac
gener
infecti
molecular
clone
known
spike
protein
clinic
isol
sar
mouseadapt
sarscov
becker
et
al
menacheri
et
al
menacheri
et
al
first
studi
deriv
infecti
molecular
clone
slbcov
sequenc
four
previous
identifi
slbcov
becker
et
al
chimer
viru
abl
replic
balbc
mous
lung
elicit
sign
respiratori
diseas
commonli
associ
sarscov
becker
et
al
similarli
chimer
replic
balbc
mous
lung
attenu
regard
caus
respiratori
diseas
menacheri
et
al
attenu
partial
overcom
infect
mice
overexpress
receptor
menacheri
et
al
indic
mous
adapt
could
enhanc
diseas
wildtyp
balbc
mice
inde
agnihothram
et
al
demonstr
mous
adapt
infecti
molecular
clone
chimer
result
dramat
respiratori
diseas
age
balbc
mice
close
relat
merscov
sinc
mous
model
avail
merscov
time
practic
replac
spike
mouseadapt
sarscov
spike
studi
demonstr
adapt
mutat
outsid
spike
necessari
elicit
respiratori
diseas
differ
mammalian
speci
howev
case
bcov
chimer
viru
caus
signific
weight
loss
balbc
mice
replic
titer
compar
sarscov
lung
moreov
wildtyp
spike
protein
support
infectionrepl
lung
balbc
mice
result
diseas
appli
classic
approach
adapt
mice
serial
passag
may
benefici
timeconsum
screen
preemerg
bcov
cc
mous
strain
potenti
rapidli
lead
mous
model
captur
differ
even
aspect
clinic
diseas
human
patient
ultim
goal
mous
model
develop
captur
diseas
etiolog
close
reflect
observ
human
cov
infect
efficaci
variou
therapeut
countermeasur
evalu
effect
resolut
pathogen
outcom
number
hcovdirect
drug
antibodi
vaccin
therapeut
evalu
efficaci
sarscov
focu
therapeut
develop
shift
merscov
review
dyall
et
al
zumla
et
al
current
fdaapprov
therapeut
specif
treatment
sarscov
merscov
variou
combinationstyp
broad
spectrum
antivir
eg
ribavirin
combin
interferon
therapi
interferon
immun
modul
eg
corticosteroid
ineffect
sarscov
merscov
case
appear
worsen
diseas
review
dyall
et
al
zumla
et
al
recent
clinic
trial
seek
interfer
merscov
replic
use
combin
therapi
includ
fdaapprov
proteas
inhibitor
lopinavir
ritonavir
http
clini
caltr
repurpos
fdaapprov
drug
interest
numer
therapeut
studi
littl
known
regard
efficaci
drug
therapeut
sarscov
merscov
outsid
cellbas
vitro
studi
review
dyall
et
al
mous
model
confer
distinct
advantag
therapeut
examin
includ
cost
save
small
scale
product
test
experiment
reproduc
recent
develop
novel
nucleotid
prodrug
demonstr
efficaci
ebola
viru
nhp
warren
et
al
sinc
move
phase
clinic
trial
ebola
http
clini
caltr
condpreva
iliv
dornemann
et
al
recent
studi
demonstr
broad
spectrum
efficaci
multipl
hcov
sarscov
merscov
preemerg
bcov
primari
human
airway
epitheli
cell
sheahan
et
al
importantli
exhibit
vivo
efficaci
sarscovinduc
immunopatholog
drug
administ
prophylact
therapeut
dose
postinfect
sheahan
et
al
delay
treatment
postinfect
amelior
diseas
symptom
although
kinet
sarscov
pathogenesi
differ
mous
human
result
indic
molecular
program
lead
respiratori
immunopatholog
establish
shortli
infect
therebi
limit
effect
therapeut
treatment
short
window
postinfect
studi
sheahan
et
al
also
demonstr
import
mous
model
recapitul
sever
respiratori
diseas
often
seen
human
sheahan
et
al
effect
therapeut
prevent
viral
replic
importantli
effect
restrict
respiratori
pathogenesi
achiev
may
requir
therapeut
intervent
combin
hcov
antivir
hostdirect
therapi
curtail
immunopatholog
associ
acut
respiratori
distress
syndrom
last
year
merscov
mous
model
describ
becom
avail
assess
therapeut
therefor
futur
studi
includ
evalu
vivo
efficaci
merscov
model
describ
ongo
threat
worldwid
public
health
plethora
therapeut
research
focus
develop
merscovspecif
antibodi
vaccin
extens
review
review
dyall
et
al
okba
et
al
importantli
studi
evalu
therapeut
efficaci
merscov
antibodi
vaccin
mammalian
challeng
model
elicit
sever
respiratori
diseas
often
result
death
cockrel
et
al
munster
et
al
tai
et
al
van
doremalen
et
al
wang
et
al
rather
mani
preclin
studi
exhibit
efficaci
mous
nhp
challeng
model
protect
defin
reduc
viral
load
lung
plaqu
assay
rtpcr
preclin
result
expedit
process
move
antibodi
vaccin
therapeut
earli
clinic
trial
review
dyall
et
al
okba
et
al
base
result
obtain
studi
critic
determin
efficaci
antibodi
vaccin
therapeut
lethal
respiratori
model
merscov
infect
vaccin
countermeasur
consid
intervent
strategi
stave
diseas
human
also
exhibit
efficaci
dromedari
camel
merscov
zoonot
host
haagman
et
al
muthumani
et
al
target
zoonot
host
dromedari
camel
bat
popul
may
effect
mean
curtail
transmiss
human
popul
think
beyond
vaccin
countermeasur
abil
har
genom
edit
technolog
could
allow
us
interven
process
zoonot
transmiss
mice
made
suscept
merscov
use
technolog
modifi
two
amino
acid
posit
mous
ortholog
amino
acid
encod
human
cockrel
et
al
genet
modif
human
orthologu
camel
bat
look
like
mous
posit
may
result
camel
bat
resist
merscov
infect
although
introduct
merscovresist
bat
environ
may
take
long
time
camel
consid
farm
anim
mani
part
northern
africa
middl
east
control
breed
practic
therefor
may
feasibl
establish
resist
herd
unabl
transmit
merscov
human
genom
edit
farm
anim
clearli
achiev
recent
demonstr
pig
modifi
genomewid
inactiv
porcin
endogen
retrovirus
perv
therebi
elimin
potenti
crossspeci
transmiss
perv
xenotransplant
pig
organ
human
intent
eas
shortag
avail
human
organ
niu
et
al
yang
et
al
combin
power
genet
engin
mice
revers
genet
system
cov
mouseadapt
genet
divers
mous
popul
afford
tool
develop
model
reproduc
recapitul
sever
respiratori
diseas
caus
hcov
human
establish
mous
model
sarscov
merscov
larg
depend
one
tool
regardless
effect
model
sarscov
merscov
studi
pathogenesi
therapeut
intervent
drawback
relat
mouseadapt
transgen
mous
model
alter
suscept
pathogenesi
hcov
acquir
mutat
associ
sever
respiratori
diseas
mouseadapt
hcov
may
bear
human
pathogenesi
alter
pathogen
outcom
human
genet
engin
specif
host
speci
enhanc
suscept
restrict
applic
mous
model
requir
crossbreed
introduc
novel
host
mutat
knockout
mous
line
cc
mous
strain
process
labor
intens
requir
extens
timelin
altern
one
could
introduc
mutat
directli
genet
divers
line
howev
cost
effect
addit
difficult
replic
studi
comorbid
mice
associ
lethal
respiratori
diseas
seen
human
preexist
condit
advanc
age
diabet
chronic
lung
diseas
heart
diseas
kidney
diseas
report
mani
severeleth
merscov
human
case
review
one
way
address
mani
concern
could
screen
genet
divers
popul
mice
eg
collabor
cross
clinic
isol
infecti
molecular
clone
wildtyp
strain
emerg
preemerg
hcov
screen
genet
divers
mous
popul
may
yield
mous
model
rang
clinic
relev
phenotyp
close
reflect
plethora
respiratori
diseas
outcom
observ
human
popul
experi
sarscov
merscov
taught
research
hcov
may
requir
uniqu
approach
mous
model
develop
mous
tool
institut
sarscov
merscov
constitut
versatil
preclin
platform
address
global
pathogen
prepared
direct
world
health
organ
open
access
articl
distribut
term
creativ
common
attribut
intern
licens
http
creat
iveco
mmon
orglicen
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
